Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATCO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-50 Cr₹-19 Cr₹12 Cr₹30 Cr₹41 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA is ₹-50 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-50 Cr
Mar2024₹-19 Cr
Mar2023₹12 Cr
Mar2022₹30 Cr
Mar2021₹41 Cr

How is Deferred Tax Assets / Liabilities of NATCO PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-50 Cr
Negative
Mar2024 ₹-19 Cr
Negative
Mar2023 ₹12 Cr
-58.80
Mar2022 ₹30 Cr
-27.12
Mar2021 ₹41 Cr -

Compare Deferred Tax Assets / Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,841.4 Cr 4.2% 2.6% -35.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,062.0 Cr -0.5% 1.8% -2% Stock Analytics
DIVIS LABORATORIES ₹164,192.0 Cr -0.3% -1.3% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,129.0 Cr 4.4% 6% 27.7% Stock Analytics
CIPLA ₹108,513.0 Cr 1% -3% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,250.0 Cr 1.1% 8% 3.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

4.2%

2.6%

-35.8%

SENSEX

-1%

-0.1%

7.9%


You may also like the below Video Courses